Testing effectiveness (Phase 2)Ended earlyNCT02221947
What this trial is testing
Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease
Who this might be right for
Alzheimer's Disease
Neurotrope Bioscience, Inc. 9